View in EDS HTML Full Text PDF Full Text

254 | RITUXIMAB AND IBRUTINIB COMBINATION IN UNTREATED SMZL AND NMZL: LONG‐TERM OUTCOME AND THE IMPACT OF EARLY MINIMAL RESIDUAL DISEASE FROM THE IELSG47/MALIBU PHASE II STUDY.

Saved in:
Bibliographic Details
Title: 254 | RITUXIMAB AND IBRUTINIB COMBINATION IN UNTREATED SMZL AND NMZL: LONG‐TERM OUTCOME AND THE IMPACT OF EARLY MINIMAL RESIDUAL DISEASE FROM THE IELSG47/MALIBU PHASE II STUDY.
Authors: Thieblemont, C., Row, C., Lamy, T., Aucagne, R., Tani, M., Merli, M., Deodato, M., Usai, S. V., Minoia, C., Bommier, C., Fournier, C., Bijou, F., Pirosa, M. C., Anastasia, A., Devizzi, L., Luminari, S., Arcaini, L., Chevreux, S., Gressin, R., André, M., et al
Source: Hematological oncology 2025 Supplement; Vol. 43.
Journal Info: Publisher: Wiley-Blackwell ISSN: 0278-0232
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: EPTOC187726204
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 254 | RITUXIMAB AND IBRUTINIB COMBINATION IN UNTREATED SMZL AND NMZL: LONG‐TERM OUTCOME AND THE IMPACT OF EARLY MINIMAL RESIDUAL DISEASE FROM THE IELSG47/MALIBU PHASE II STUDY.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Thieblemont%2C+C%2E%22">Thieblemont, C.</searchLink><br /><searchLink fieldCode="AU" term="%22Row%2C+C%2E%22">Row, C.</searchLink><br /><searchLink fieldCode="AU" term="%22Lamy%2C+T%2E%22">Lamy, T.</searchLink><br /><searchLink fieldCode="AU" term="%22Aucagne%2C+R%2E%22">Aucagne, R.</searchLink><br /><searchLink fieldCode="AU" term="%22Tani%2C+M%2E%22">Tani, M.</searchLink><br /><searchLink fieldCode="AU" term="%22Merli%2C+M%2E%22">Merli, M.</searchLink><br /><searchLink fieldCode="AU" term="%22Deodato%2C+M%2E%22">Deodato, M.</searchLink><br /><searchLink fieldCode="AU" term="%22Usai%2C+S%2E+V%2E%22">Usai, S. V.</searchLink><br /><searchLink fieldCode="AU" term="%22Minoia%2C+C%2E%22">Minoia, C.</searchLink><br /><searchLink fieldCode="AU" term="%22Bommier%2C+C%2E%22">Bommier, C.</searchLink><br /><searchLink fieldCode="AU" term="%22Fournier%2C+C%2E%22">Fournier, C.</searchLink><br /><searchLink fieldCode="AU" term="%22Bijou%2C+F%2E%22">Bijou, F.</searchLink><br /><searchLink fieldCode="AU" term="%22Pirosa%2C+M%2E+C%2E%22">Pirosa, M. C.</searchLink><br /><searchLink fieldCode="AU" term="%22Anastasia%2C+A%2E%22">Anastasia, A.</searchLink><br /><searchLink fieldCode="AU" term="%22Devizzi%2C+L%2E%22">Devizzi, L.</searchLink><br /><searchLink fieldCode="AU" term="%22Luminari%2C+S%2E%22">Luminari, S.</searchLink><br /><searchLink fieldCode="AU" term="%22Arcaini%2C+L%2E%22">Arcaini, L.</searchLink><br /><searchLink fieldCode="AU" term="%22Chevreux%2C+S%2E%22">Chevreux, S.</searchLink><br /><searchLink fieldCode="AU" term="%22Gressin%2C+R%2E%22">Gressin, R.</searchLink><br /><searchLink fieldCode="AU" term="%22André%2C+M%2E%22">André, M.</searchLink><br />et al
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228307268%22">Hematological oncology</searchLink> 2025 Supplement; Vol. 43.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>ISSN: </i>0278-0232
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=EPTOC187726204
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/hon.70094_254
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1
    Titles:
      – TitleFull: 254 | RITUXIMAB AND IBRUTINIB COMBINATION IN UNTREATED SMZL AND NMZL: LONG‐TERM OUTCOME AND THE IMPACT OF EARLY MINIMAL RESIDUAL DISEASE FROM THE IELSG47/MALIBU PHASE II STUDY.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Thieblemont, C.
      – PersonEntity:
          Name:
            NameFull: Row, C.
      – PersonEntity:
          Name:
            NameFull: Lamy, T.
      – PersonEntity:
          Name:
            NameFull: Aucagne, R.
      – PersonEntity:
          Name:
            NameFull: Tani, M.
      – PersonEntity:
          Name:
            NameFull: Merli, M.
      – PersonEntity:
          Name:
            NameFull: Deodato, M.
      – PersonEntity:
          Name:
            NameFull: Usai, S. V.
      – PersonEntity:
          Name:
            NameFull: Minoia, C.
      – PersonEntity:
          Name:
            NameFull: Bommier, C.
      – PersonEntity:
          Name:
            NameFull: Fournier, C.
      – PersonEntity:
          Name:
            NameFull: Bijou, F.
      – PersonEntity:
          Name:
            NameFull: Pirosa, M. C.
      – PersonEntity:
          Name:
            NameFull: Anastasia, A.
      – PersonEntity:
          Name:
            NameFull: Devizzi, L.
      – PersonEntity:
          Name:
            NameFull: Luminari, S.
      – PersonEntity:
          Name:
            NameFull: Arcaini, L.
      – PersonEntity:
          Name:
            NameFull: Chevreux, S.
      – PersonEntity:
          Name:
            NameFull: Gressin, R.
      – PersonEntity:
          Name:
            NameFull: André, M.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 06
              Text: 2025 Supplement
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 1099-1069
          Numbering:
            – Type: volume
              Value: 43
          Titles:
            – TitleFull: Hematological oncology
              Type: main
ResultId 1